Skip to content

Clinical trials

Phase 4 Coronary Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Disease Phase: Phase 4 Clear all

158 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20023
20037
200410
20058
200616
200715
20087
20098
201013
20119
20129
20136
20144
20157
20164
20173
20181
20196
20205
20214
20221
20231
20243
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed98
Unknown status43
Terminated8
Recruiting3
Withdrawn3
Not yet recruiting2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Deutsches Herzzentrum Muenchen22
Seung-Jung Park6
Abbott Medical Devices5
China National Center for Cardiovascular Diseases4
Guang'anmen Hospital of China Academy of Chinese Medical Sciences4
Organon and Co3
Seoul National University Hospital3
Beijing Anzhen Hospital2
CHEOL WHAN LEE, M.D., Ph.D2
Johns Hopkins University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Disease158
Coronary Artery Disease32
Cardiovascular Diseases17
Atherosclerosis14
Myocardial Ischemia12
Heart Diseases11
Acute Coronary Syndrome10
Diabetes Mellitus10
Arteriosclerosis9
Angina Pectoris8

Trials

Showing 51 to 75 of 158. Each trial links to its page on Pharma Observatory.

58 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.